|
1
|
Lin D, Sutherland D, Aninta SI, Louie N, Nip KM, Li C, Yanai A, Coombe L, Warren RL, Helbing CC, Hoang LMN, Birol I. Mining Amphibian and Insect Transcriptomes for Antimicrobial Peptide Sequences with rAMPage. Antibiotics (Basel) 2022; 11:antibiotics11070952. [PMID: 35884206 PMCID: PMC9312091 DOI: 10.3390/antibiotics11070952] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Revised: 07/12/2022] [Accepted: 07/13/2022] [Indexed: 02/01/2023] Open
Abstract
Antibiotic resistance is a global health crisis increasing in prevalence every day. To combat this crisis, alternative antimicrobial therapeutics are urgently needed. Antimicrobial peptides (AMPs), a family of short defense proteins, are produced naturally by all organisms and hold great potential as effective alternatives to small molecule antibiotics. Here, we present rAMPage, a scalable bioinformatics discovery platform for identifying AMP sequences from RNA sequencing (RNA-seq) datasets. In our study, we demonstrate the utility and scalability of rAMPage, running it on 84 publicly available RNA-seq datasets from 75 amphibian and insect species—species known to have rich AMP repertoires. Across these datasets, we identified 1137 putative AMPs, 1024 of which were deemed novel by a homology search in cataloged AMPs in public databases. We selected 21 peptide sequences from this set for antimicrobial susceptibility testing against Escherichia coli and Staphylococcus aureus and observed that seven of them have high antimicrobial activity. Our study illustrates how in silico methods such as rAMPage can enable the fast and efficient discovery of novel antimicrobial peptides as an effective first step in the strenuous process of antimicrobial drug development.
Collapse
Affiliation(s)
- Diana Lin
- Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC V5Z 4S6, Canada; (D.L.); (D.S.); (S.I.A.); (N.L.); (K.M.N.); (C.L.); (A.Y.); (L.C.); (R.L.W.)
| | - Darcy Sutherland
- Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC V5Z 4S6, Canada; (D.L.); (D.S.); (S.I.A.); (N.L.); (K.M.N.); (C.L.); (A.Y.); (L.C.); (R.L.W.)
- British Columbia Centre for Disease Control, Public Health Laboratory, Vancouver, BC V6Z R4R, Canada;
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
| | - Sambina Islam Aninta
- Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC V5Z 4S6, Canada; (D.L.); (D.S.); (S.I.A.); (N.L.); (K.M.N.); (C.L.); (A.Y.); (L.C.); (R.L.W.)
| | - Nathan Louie
- Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC V5Z 4S6, Canada; (D.L.); (D.S.); (S.I.A.); (N.L.); (K.M.N.); (C.L.); (A.Y.); (L.C.); (R.L.W.)
| | - Ka Ming Nip
- Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC V5Z 4S6, Canada; (D.L.); (D.S.); (S.I.A.); (N.L.); (K.M.N.); (C.L.); (A.Y.); (L.C.); (R.L.W.)
- Bioinformatics Graduate Program, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
| | - Chenkai Li
- Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC V5Z 4S6, Canada; (D.L.); (D.S.); (S.I.A.); (N.L.); (K.M.N.); (C.L.); (A.Y.); (L.C.); (R.L.W.)
- Bioinformatics Graduate Program, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
| | - Anat Yanai
- Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC V5Z 4S6, Canada; (D.L.); (D.S.); (S.I.A.); (N.L.); (K.M.N.); (C.L.); (A.Y.); (L.C.); (R.L.W.)
| | - Lauren Coombe
- Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC V5Z 4S6, Canada; (D.L.); (D.S.); (S.I.A.); (N.L.); (K.M.N.); (C.L.); (A.Y.); (L.C.); (R.L.W.)
| | - René L. Warren
- Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC V5Z 4S6, Canada; (D.L.); (D.S.); (S.I.A.); (N.L.); (K.M.N.); (C.L.); (A.Y.); (L.C.); (R.L.W.)
| | - Caren C. Helbing
- Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada;
| | - Linda M. N. Hoang
- British Columbia Centre for Disease Control, Public Health Laboratory, Vancouver, BC V6Z R4R, Canada;
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
| | - Inanc Birol
- Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC V5Z 4S6, Canada; (D.L.); (D.S.); (S.I.A.); (N.L.); (K.M.N.); (C.L.); (A.Y.); (L.C.); (R.L.W.)
- British Columbia Centre for Disease Control, Public Health Laboratory, Vancouver, BC V6Z R4R, Canada;
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
- Correspondence:
| |
Collapse
|